hearing/vestibular/ear
|
• extensive degeneration at P3
|
nervous system
|
• extensive degeneration at P3
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Pou4f3em1(cre/ERT2)Yss endonuclease-mediated mutation 1, Yun Stone Shi MGI:6693366 |
||||||||||||||||||||
| Summary |
4 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• extensive degeneration at P3
|
|
• extensive degeneration at P3
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• significantly degenerated at 32 kHz at 3 months of age
|
|
• reduced peak 1 amplitudes at across all frequencies at 3 months of age
|
|
• increased at 32 kHz at 3 months of age
|
|
• increased at 32 kHz at 3 months of age
|
|
• significantly degenerated at 32 kHz at 3 months of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• significantly loss at multiple frequencies at 9 months of age
|
|
• at 9 months of age
|
|
• at 9 months of age
|
|
• at 9 months of age
|
|
• at 9 months of age
|
|
• significantly loss at multiple frequencies at 9 months of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in tamoxifen-treated mice
|
|
• auditory brainstem response thresholds are elevated in tamoxifen-treated mice
|
|
• distortion product otoacoustic emission thresholds are elevated in tamoxifen-treated mice
|
|
• tamoxifen-treated mice exhibit hearing loss
|
|
• in tamoxifen-treated mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


